Biotech

All Articles

Novartis fires up new phase of Voyager contract with $15M capsid offer

.Novartis is opening a brand new frontier in its own cooperation with Voyager Therapeutics, paying $...

Lilly messages more positive data on its weekly the hormone insulin prospect

.On the heels of an FDA turndown for its main rivalrous Novo Nordisk, Eli Lilly is actually picking ...

IN 8bio standstills phase 2 test, lays off fifty percent of workforce

.Just a handful of months after application the 1st individual in a period 2 test for recently detec...

Lilly, Haya ink $1B biobuck excessive weight pact to look black genome

.Eli Lilly's look for being overweight targets has led it to the darker genome. The Big Pharma has a...

ArsenalBio raises $325M, rotates far from past lead property

.Arsenal Biosciences is actually proceeding up. The tissue therapy business has added $325 thousand ...

Lilly- supported weight loss biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis make use of drug flunks phase 2b, driving Indivior to rethink $100M alternative

.Aelis Farma's chances of safeguarding a simple, favorable selection on a $one hundred million optio...

ProKidney stops period 3 test not needed for cell treatment permission

.ProKidney has quit some of a set of stage 3 trials for its own tissue therapy for kidney illness af...

Vaxcyte climbs on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals named "magnificent" period 1/2 information for its own 31-valen...

Recursion's human brain health condition trial reveals scant evidence of effectiveness

.Recursion has stumbled with a very early exam of its tech-enabled approach to medication revelation...